XML 18 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Reconciliation of net loss to cash used by operating activities:    
Net loss $ (4,784) $ (1,961)
Add (deduct):    
Depreciation and amortization 5,990 6,234
Provision for bad debt 446 (143)
Investment and other (gains) losses – net (3,403) 1,671
Amortization of net premium on debt securities investments 1,353 1,587
Payments for title losses (in excess of) less than provisions (7,781) 710
Adjustment for insurance recoveries of title losses 380 1,198
Increase in receivables – net (5,686) (3,321)
Increase in other assets – net (815) (4,853)
Decrease in accounts payable and other liabilities – net (26,212) (30,258)
Change in net deferred income taxes (252) (161)
Net income from equity investees (374) (243)
Dividends received from equity investees 353 431
Stock-based compensation expense 804 140
Other – net 98 43
Cash used by operating activities (39,883) (28,926)
Investing activities:    
Proceeds from sales of investments in securities 6,958 15,366
Proceeds from matured investments in debt securities 20,094 4,603
Purchases of investments in securities (561) (8,042)
Net (purchases) sales of short-term investments (456) 63
Purchases of property and equipment, and real estate – net (2,735) (1,993)
Cash paid for acquisition of businesses 0 (11,978)
Other – net 1,287 464
Cash provided (used) by investing activities 24,587 (1,517)
Financing activities:    
Payments on notes payable (7,446) (5,029)
Proceeds from notes payable 4,454 0
Distributions to noncontrolling interests (3,177) (2,928)
Repurchases of common stock (379) (579)
Cash dividends paid (7,083) (7,061)
Purchase of remaining interest in consolidated subsidiary 0 (281)
Cash used by financing activities (13,631) (15,878)
Effects of changes in foreign currency exchange rates 1,367 (284)
Decrease in cash and cash equivalents (27,560) (46,605)
Cash and cash equivalents at beginning of period 192,067 150,079
Cash and cash equivalents at end of period $ 164,507 $ 103,474